Physician

Cara-Louise Fox, MD

According to 2025 Medicare claims, Cara-Louise Fox, MD (NPI: 1770807521) practices family practice in the Carson City, NV market, with the plurality of this provider's patient population coming from Carson City, NV. This provider's primary affiliated billing organization is CARSON MEDICAL GROUP PROFESSIONAL CORPORATION (NPI: 1780694620; TIN: 880133501) and primary practice location at 89706-0674. Fox is affiliated with the Silver State ACO LLC (ACO ID: A2251) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Fox's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 424 traditional Medicare patients, billed 2,596 HCPCS/CPT codes, and received $144,112 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 5,457 prescription claims across 500 beneficiaries totaling $371,065 in drug costs, led by Eliquis (Apixaban). DME data shows 41 claims. Open Payments data shows 14 records totaling $247. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $72,351 to $144,112. Similarly, Part D prescription costs have risen steadily, from $178,875 to $371,065. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $11,351 to $4,381.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	326	1,105	$72,351
2016	357	1,245	$78,413
2017	456	1,637	$112,284
2018	481	1,723	$115,323
2019	491	1,663	$116,024
2020	591	2,873	$156,981
2021	608	2,822	$155,549
2022	595	2,471	$156,876
2023	425	1,991	$128,597
2024	424	2,596	$144,112

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	267	2,867	$178,875
2016	300	3,616	$204,778
2017	381	4,537	$248,048
2018	394	4,572	$245,540
2019	408	4,546	$239,744
2020	454	5,107	$315,005
2021	478	4,925	$338,699
2022	506	5,309	$361,297
2023	496	4,900	$331,175
2024	500	5,457	$371,065

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	179	$10,572
2016	16	232	$8,178
2017	30	234	$13,743
2018	14	211	$15,812
2019	28	232	$19,077
2020	14	173	$12,517
2021	14	125	$6,511
2022	11	73	$2,998
2023	N/R	137	$8,371
2024	N/R	41	$2,792

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	218	218	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	302	420	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	125	154	$53
77080	Dxa bone density measurement of hip, pelvis, spine	106	106	$37
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	306	436	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	56	3,704	$70,392
Jardiance	Empagliflozin	25	1,770	$32,260
Ozempic	Semaglutide	12	616	$18,443
Farxiga	Dapagliflozin Propanediol	21	930	$16,510
Linzess	Linaclotide	17	870	$15,090

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	29	$2,363
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$429

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$247	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Cara-Louise Fox, MD?

Tedicare shows public-source Medicare data for Cara-Louise Fox, MD (NPI 1770807521), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cara-Louise Fox, MD have ACO affiliation data?

Cara-Louise Fox, MD is shown with ACO affiliation data for Silver State ACO LLC (MSSP, ACO ID A2251) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Cara-Louise Fox, MD?

Cara-Louise Fox, MD is linked to CARSON MEDICAL GROUP PROFESSIONAL CORPORATION (billing NPI 1780694620) in the available physician profile data.

Does Cara-Louise Fox, MD have Open Payments data?

Cara-Louise Fox, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.